BIRLAMCHI TIBBIY-SANITARIYA YORDAMIDA O‘TKIR YURAK-QON TOMIR KASALLIKLARINING PROFILAKTIKASINI TAKOMILLASHTIRISH
PDF

Keywords

birlamchi tibbiy-sanitariya yordami, o‘tkir yurak-qon tomir kasalliklari, profilaktika, xavf omillari, oilaviy shifokor, arterial gipertenziya, SCORE2, dispanserizatsiya, raqamli sog‘liqni saqlash.

How to Cite

Siddiqov Tursinali o‘g‘li, B. (2026). BIRLAMCHI TIBBIY-SANITARIYA YORDAMIDA O‘TKIR YURAK-QON TOMIR KASALLIKLARINING PROFILAKTIKASINI TAKOMILLASHTIRISH . JOURNAL OF SCIENCE-INNOVATIVE RESEARCH IN UZBEKISTAN, 4(04), 29–40. Retrieved from https://scienceinno.org/index.php/jsiru/article/view/140

Abstract

Ushbu maqolada birlamchi tibbiy-sanitariya yordam (BTSYo) tizimida o‘tkir yurak-qon tomir kasalliklari (YuQTK) profilaktikasini takomillashtirish masalalari PRISMA tamoyillariga muvofiq tuzilgan zamonaviy adabiyotlar sharhi asosida yoritilgan. Jahon sog‘liqni saqlash tashkiloti (JSST) va Yevropa kardiologiya jamiyati 2021–2024 yillardagi qo‘llanmalari, shuningdek O‘zbekiston Respublikasida o‘tkazilgan epidemiologik tadqiqotlar tahlil qilingan.

Maqolada xavf omillarini erta aniqlash, profilaktik tadbirlarning samaradorligi, raqamli texnologiyalarning roli va O‘zbekiston Respublikasi Sog‘liqni saqlash tizimidagi BTSYo xizmatining olib borayotgan faoliyatidagi tizimli muammolar ko‘rib chiqilgan. Tahlil natijasi shuni ko‘rsatadiki, BTSYo tizimida SCORE2 kalkulyatoriga asoslangan kompleks kardiovaskular profilaktika o‘tkir YuQTK bilan bog‘liq o‘limni 30–45% ga kamaytirishi mumkin [5, 30]. Maqola oxirida O‘zbekiston Respublikasi Sog‘liqni saqlash tizimi uchun amaliy tavsiyalar keltirilgan.

PDF

References

1. World Health Organization. Cardiovascular diseases (CVDs). Key facts. Geneva: WHO, 2023. URL: https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases-(cvds)

2. European Observatory on Health Systems and Policies. Health systems in action 2024: Uzbekistan. Copenhagen: WHO/Europe, 2024.

3. D.Turg‘unboyev Cardiovascular Diseases in Uzbekistan: Causes, Prevention, and Treatment. European Journal of Medical and Health Research. 2025; 3(6): 67-70. DOI: 10.59324/ejmhr.2025.3(6).11

4. S.Nazirova The Burden of Cardiovascular Diseases in Uzbekistan: A Growing Public Health Concern. Journal of Multidisciplinary Sciences and Innovations. 2025; 1(6): 30-34.

5. Visseren FLJ, et al. 2021 ESC Guidelines on Cardiovascular Disease Prevention in Clinical Practice. European Heart Journal. 2021; 42: 3227-3337. DOI: 10.1093/eurheartj/ehab484

6. WHO/Europe. Avoidable mortality, risk factors and policies for tackling noncommunicable diseases — leveraging data for impact. Kazakhstan report. Copenhagen: WHO/Europe, 2025.

7. Roth GA, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019. Journal of the American College of Cardiology. 2020; 76: 2982-3021.

8. Baigent C, et al. (Cholesterol Treatment Trialists' Collaboration). Efficacy and Safety of LDL-Lowering Therapy Among Men and Women. Lancet. 2022; 400: 1122-1130.

9. Lincoff AM, et al. (SELECT Trial). Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. New England Journal of Medicine. 2023; 389: 2221-2232.

10. Neubeck L, et al. Telehealth Interventions for the Secondary Prevention of Coronary Heart Disease: A Systematic Review and Meta-Analysis. Cochrane Database of Systematic Reviews. 2022. DOI: 10.1002/14651858.CD013820

11. Sutton RT, et al. An Overview of Clinical Decision Support Systems: Benefits, Risks, and Strategies for Success. NPJ Digital Medicine. 2023; 3: 17.

12. Orrow G, et al. Effectiveness of Physical Activity Promotion in Primary Care: Systematic Review and Meta-Analysis. BMJ. 2023; 376: e066426.

13. World Heart Federation. Uzbekistan — World Heart Observatory country profile. Geneva, 2023. URL: https://world-heart-federation.org/world-heart-observatory/countries/uzbekistan/

14. Rahimi K, et al. Pharmacological Blood Pressure Lowering for Primary and Secondary Prevention of Cardiovascular Disease. Lancet. 2021; 397: 1625-1636. DOI: 10.1016/S0140-6736(21)00590-0

15. Whelton PK, et al. 2017 ACC/AHA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults. Journal of the American College of Cardiology. 2018; 71: e127-e248. [Updated 2023]

16. WHO. Global Action Plan on Physical Activity 2018-2030: More Active People for a Healthier World. Updated monitoring report 2022. Geneva: WHO, 2022.

17. Wahid A, et al. Quantifying the Association Between Physical Activity and Cardiovascular Disease and Diabetes. Journal of the American Heart Association. 2016; 5: e002495.

18. Schillinger D, et al. Health Literacy and Cardiovascular Disease: Fundamental Relevance to Primary Care. Journal of the American College of Cardiology. 2021; 77(21): 2780-2783. DOI: 10.1016/j.jacc.2021.04.001

19. Jousilahti P, et al. Primary Prevention and Risk Factor Reduction in Coronary Heart Disease Mortality. BMJ. 2021; 374: n2384. DOI: 10.1136/bmj.n2384

20. NHS England. NHS Health Check National Programme: Programme Review 2022. London: NHS England, 2022.

21. Kario K, et al. Digital Health Interventions for Hypertension Management in Primary Care: A Meta-Analysis. Journal of the American Heart Association. 2024; 13(4): e031245.

22. Rollnick S, Miller WR, Butler CC. Motivational Interviewing in Health Care: Helping Patients Change Behavior. 2nd ed. New York: Guilford Press, 2023.

23. World Health Organization. Making the investment case for prevention: return on investment for noncommunicable disease prevention. Geneva: WHO, 2023. URL: https://www.who.int/publications/i/item/9789240073487

24. O‘zbekiston Respublikasi Prezidentining «Sog‘lom O‘zbekiston» milliy dasturi to‘g‘risida Farmoni. Toshkent, 2020.

25. O‘zbekiston Respublikasi Sog‘liqni saqlash vazirligi. Yillik sog‘liqni saqlash statistikasi to‘g‘risida hisobot. Toshkent, 2024.

26. G.Mamlajiyeva J.Qodirov L.Yunusova Oilaviy poliklinikalarda kardiovaskular profilaktikaning ahvoli. O‘zbekiston Respublikasi tibbiyot jurnali. 2022; (3): 45-51.

27. N.Raximov L.Yunusova Toshkent shahri BTSYo muassasalarida dispanserizatsiyaning samaradorligi. Sog‘liqni saqlash. 2023; (1): 18-24.

28. Mach F, et al. 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias. European Heart Journal. 2020; 41: 111-188.

29. Lindson N, et al. Different Doses, Durations and Modes of Delivery of Varenicline for Smoking Cessation (EAGLES-2). Cochrane Database of Systematic Reviews. 2023. DOI: 10.1002/14651858.CD013920.pub2

30. GBD 2019 Risk Factors Collaborators. Global Burden of 87 Risk Factors in 204 Countries and Territories, 1990-2019. Lancet. 2020; 396: 1223-1249. DOI: 10.1016/S0140-6736(20)30752-2

31. Ilesanmi OS, et al. Burden of the Cardiovascular Diseases in Central Asia: Systematic Analysis. BMC Public Health. 2022; 22: 2148. DOI: 10.1186/s12889-022-14593-3